P. Busse

I. Kaplan, M. Palmer, P. Busse, 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy.

J. T. Goorley, M. Palmer, P. Busse, 2002, International journal of radiation oncology, biology, physics.

A Pharmacokinetic Model for the Concentration of 10B in Blood after Boronophenylalanine-Fructose Administration in Humans

M. Palmer, P. Busse, K. Riley, 2001, Radiation research.

Analysis of Radiation Therapy for the Control of Merkel Cell Carcinoma of the Head and Neck Based on 36 Cases and a Literature Review

E. Baldini, D. Deschler, L. Kachnic, 2008, Ear, nose, & throat journal.

NCCN Guidelines ® Insights Head and Neck Cancers , Version 1 . 2018 Featured Updates to the NCCN Guidelines

R. Weber, A. Jimeno, M. Witek, 2018 .

Combined-modality therapy of esophageal cancer with radiotherapy, etanidazole, and cisplatin-fluorouracil, with or without surgery: neurotoxicity, other toxicities and outcome.

C. Coleman, A. Recht, P. Busse, 1994, International journal of radiation oncology, biology, physics.

Synergistic killing of Hela cells by hydroxyurea and caffeine

L. Tolmach, P. Busse, K. L. Beetham, 1983, Journal of cellular physiology.

Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.

R. Tishler, P. Busse, A. Mahadevan, 2006, International journal of radiation oncology, biology, physics.

Head and Neck Cancers, Version 2.2013

K. Ang, J. Shah, R. Weber, 2013 .

Head and Neck Cancers , Version 1 . 2015 Featured Updates to the NCCN Guidelines

J. Shah, R. Weber, D. Brizel, 2015 .

Effect of combined modality therapy on the surgical management of locally advanced rectal carcinoma.

B. Cady, J. Jessup, P. Busse, 1993, Seminars in surgical oncology.

IOERT Treatment Factors

C. Willett, J. Tepper, D. Nagorney, 1999 .

Nasal Cavity and Paranasal Sinus Cancers

Christopher U. Jones, J. Cooper, S. Yom, 2016 .

Case records of the Massachusetts General Hospital. Case 19-2008. A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma.

V. Muse, P. Busse, J. Clark, 2008, The New England journal of medicine.

Case 19-2008 : A 63-Year-Old HIV-Positive Man with Cutaneous Merkel-Cell Carcinoma

V. Muse, P. Busse, J. Clark, 2008 .

Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck.

R. Tishler, P. Busse, A. Allen, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

ACR Appropriateness Criteria® Neck Mass-Adenopathy.

Christopher U. Jones, L. Shah, J. Aulino, 2019, Journal of the American College of Radiology : JACR.

Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.

A. Niemierko, H. Shih, C. Belka, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies.

R. Tishler, P. Busse, E. Peters, 1999, International journal of radiation oncology, biology, physics.

A Critical Examination of the Results from the Harvard-MIT NCT Program Phase I Clinical Trial of Neutron Capture Therapy for Intracranial Disease

I. Kaplan, M. Palmer, C. Chuang, 2004, Journal of Neuro-Oncology.

The Fission Converter-Based Epithermal Neutron Irradiation Facility at the Massachusetts Institute of Technology Reactor

John A. Bernard, P. T. Menadier, Gordon Kohse, 2002 .

A Pharmacokinetic Model for the Concentration of Boron-10 in Blood Following Boronophenylalanine-Fructose Administration in Humans

M. Palmer, P. Busse, R. Zamenhof, 2001 .

Functional and Histological Changes in Rat Lung after Boron Neutron Capture Therapy

J. Hopewell, P. Busse, O. Harling, 2008, Radiation research.

Neck Mass/Adenopathy

Christopher, Lee, U., 2018 .

ACR Appropriateness Criteria® Locoregional therapy for resectable oropharyngeal squamous cell carcinomas

Christopher U. Jones, J. Cooper, S. Yom, 2016, Head & neck.

Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.

D. Hayes, D. Deschler, P. Busse, 2019, Journal of the National Cancer Institute.

Preservation of Sphincter Function in Rectal Carcinoma by a Multimodality Treatment Approach

R. Mayer, J. Jessup, P. Busse, 1992 .

Intensity‐modulated versus conventional radiation therapy for oropharyngeal carcinoma: Long‐term dysphagia and tumor control outcomes

P. Busse, S. McBride, J. Jang, 2014, Head & neck.

ACR Appropriateness criteria® for nasopharyngeal carcinoma

Christopher U. Jones, J. Cooper, S. Yom, 2016, Head & neck.

A Phase II Trial of Proton Radiation Therapy With Chemotherapy for Nasopharyngeal Carcinoma

T. Delaney, P. Busse, P. Busse, 2012 .

Swallowing Function After Proton Beam Therapy for Nasopharyngeal Cancer: A Prospective Study

P. Busse, L. Wirth, S. Rothenberg, 2012 .

Large anatomical changes in head-and-neck cancers - A dosimetric comparison of online and offline adaptive proton therapy.

A. Lomax, G. Sharp, J. Verburg, 2023, Clinical and translational radiation oncology.

Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.

A. Garden, C. Fuller, B. Vikram, 2018, Seminars in radiation oncology.

Factors Associated With Prolonged Gastrostomy Tube Usage in Patients With Oropharyngeal Cancer Treated With Chemoradiation

P. Busse, L. Wirth, J. Jang, 2012 .

The Harvard-MIT BNCT Program

I. Kaplan, M. Palmer, C. Chuang, 2001 .

Primary site management following induction chemotherapy with cis‐platinum, 5‐fluorouracil, and leucovorin

P. Busse, C. Beard, C. Norris, 1993, Head & neck.

Head and Neck: Editorial

J. J. Coleman, S. Ariyan, L. Delclos, 2001 .

Extensive basal cell carcinoma of the face: an extreme case of denial.

P. Busse, S. Zaghi, K. Emerick, 2014, Ear, nose, & throat journal.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

J. Shah, R. Weber, A. Jimeno, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

R. Weber, A. Jimeno, M. Witek, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Intraoperative radiation therapy for carcinoma of the gallbladder

B. Cady, P. Busse, R. Jenkins, 1991, World Journal of Surgery.

A pilot study of sphincter-sparing management of adenocarcinoma of the rectum.

T. Ravikumar, R. Mayer, J. Jessup, 1991, Archives of surgery.

Neoadjuvant therapy for unresectable pancreatic adenocarcinoma.

B. Cady, R. Mayer, J. Jessup, 1993, Archives of surgery.

Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.

P. Busse, P. Busse, P. Prasad, 1999, Medical physics.

on Neurologic Imaging: